PL311702A1 - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- PL311702A1 PL311702A1 PL94311702A PL31170294A PL311702A1 PL 311702 A1 PL311702 A1 PL 311702A1 PL 94311702 A PL94311702 A PL 94311702A PL 31170294 A PL31170294 A PL 31170294A PL 311702 A1 PL311702 A1 PL 311702A1
- Authority
- PL
- Poland
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310635A GB9310635D0 (en) | 1993-05-21 | 1993-05-21 | Chemical compounds |
| PCT/EP1994/001613 WO1994027989A1 (en) | 1993-05-21 | 1994-05-19 | Carbazole derivatives with 17,20-lyase-inhibiting activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL311702A1 true PL311702A1 (en) | 1996-03-04 |
Family
ID=10736007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL94311702A PL311702A1 (en) | 1993-05-21 | 1994-05-19 | Chemical compounds |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0699196A1 (en) |
| JP (1) | JPH08510455A (en) |
| CN (1) | CN1126473A (en) |
| AU (1) | AU6928794A (en) |
| BG (1) | BG100154A (en) |
| CA (1) | CA2162921A1 (en) |
| CZ (1) | CZ305195A3 (en) |
| FI (1) | FI955587A (en) |
| GB (1) | GB9310635D0 (en) |
| HU (1) | HUT73790A (en) |
| IL (1) | IL109703A0 (en) |
| NO (1) | NO954681D0 (en) |
| OA (1) | OA10195A (en) |
| PE (1) | PE31195A1 (en) |
| PL (1) | PL311702A1 (en) |
| SK (1) | SK142495A3 (en) |
| TW (1) | TW279866B (en) |
| WO (1) | WO1994027989A1 (en) |
| ZA (1) | ZA943494B (en) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995009157A1 (en) * | 1993-09-30 | 1995-04-06 | Yamanouchi Pharmaceutical Co., Ltd. | Azole derivative and pharmaceutical composition thereof |
| AU3846395A (en) * | 1994-11-07 | 1996-05-31 | Janssen Pharmaceutica N.V. | Compositions comprising carbazoles and cyclodextrins |
| AU702406B2 (en) * | 1995-03-01 | 1999-02-18 | Yamanouchi Pharmaceutical Co., Ltd. | Imidazole derivatives and medicinal composition thereof |
| AU6229698A (en) * | 1997-02-21 | 1998-09-09 | Takeda Chemical Industries Ltd. | Fused ring compounds, process for producing the same and use thereof |
| KR100725442B1 (en) | 2000-11-17 | 2007-06-07 | 다케다 야쿠힌 고교 가부시키가이샤 | Novel imidazole derivatives, production method thereof and use thereof |
| AU2002214320A1 (en) | 2000-11-20 | 2002-05-27 | Takeda Chemical Industries Ltd. | Imidazole derivatives, process for their preparation and their use |
| AU2002221080A1 (en) | 2000-12-08 | 2002-06-18 | Masami Kusaka | Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparingthe same and use thereof |
| CN101203491A (en) | 2005-06-24 | 2008-06-18 | 伊莱利利公司 | Tetrahydrocarbazole derivatives used as androgen receptor modifier |
| GB0525323D0 (en) * | 2005-12-13 | 2006-01-18 | Sterix Ltd | Compound |
| US8093279B2 (en) | 2005-12-13 | 2012-01-10 | Gillian Reed, legal representative | Compound |
| CN100586932C (en) * | 2007-01-26 | 2010-02-03 | 中国医学科学院医药生物技术研究所 | Antitumor compound and its preparation process |
| MY155570A (en) | 2009-06-26 | 2015-10-30 | Novartis Ag | 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17 |
| EP2531029B1 (en) * | 2010-02-04 | 2016-10-19 | Radius Health, Inc. | Selective androgen receptor modulators |
| WO2011143469A1 (en) | 2010-05-12 | 2011-11-17 | Radius Health,Inc | Therapeutic regimens |
| WO2012018948A2 (en) | 2010-08-04 | 2012-02-09 | Pellficure Pharmaceuticals, Inc. | Novel treatment of prostate carcinoma |
| WO2012035078A1 (en) | 2010-09-16 | 2012-03-22 | Novartis Ag | 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS |
| WO2012047617A1 (en) | 2010-09-28 | 2012-04-12 | Radius Health, Inc. | Selective androgen receptor modulators |
| EP2702052B1 (en) | 2011-04-28 | 2017-10-18 | Novartis AG | 17alpha-hydroxylase/c17,20-lyase inhibitors |
| US9492460B2 (en) * | 2013-02-27 | 2016-11-15 | Bristol-Myers Squibb Company | Carbazole compounds useful as bromodomain inhibitors |
| US20160022606A1 (en) | 2013-03-14 | 2016-01-28 | Pellficure Pharmaceuticals Inc. | Novel therapy for prostate carcinoma |
| EP3834824A1 (en) | 2014-03-28 | 2021-06-16 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
| US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
| US10093620B2 (en) | 2014-09-12 | 2018-10-09 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
| WO2017223115A1 (en) | 2016-06-22 | 2017-12-28 | Radius Health, Inc. | Ar+ breast cancer treatment methods |
| EP3528799A1 (en) | 2016-10-24 | 2019-08-28 | Pellficure Pharmaceuticals, Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione |
| JP7481115B2 (en) | 2017-01-05 | 2024-05-10 | ラジウス ファーマシューティカルズ，インコーポレイテッド | Polymorphic forms of RAD1901-2HCL |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
| GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
-
1993
- 1993-05-21 GB GB939310635A patent/GB9310635D0/en active Pending
-
1994
- 1994-05-02 ZA ZA943494A patent/ZA943494B/en unknown
- 1994-05-17 TW TW083104441A patent/TW279866B/zh active
- 1994-05-19 WO PCT/EP1994/001613 patent/WO1994027989A1/en not_active Application Discontinuation
- 1994-05-19 JP JP7500181A patent/JPH08510455A/en active Pending
- 1994-05-19 HU HU9503321A patent/HUT73790A/en unknown
- 1994-05-19 CN CN94192683A patent/CN1126473A/en active Pending
- 1994-05-19 AU AU69287/94A patent/AU6928794A/en not_active Abandoned
- 1994-05-19 PL PL94311702A patent/PL311702A1/en unknown
- 1994-05-19 CA CA002162921A patent/CA2162921A1/en not_active Abandoned
- 1994-05-19 CZ CZ953051A patent/CZ305195A3/en unknown
- 1994-05-19 SK SK1424-95A patent/SK142495A3/en unknown
- 1994-05-19 EP EP94917647A patent/EP0699196A1/en not_active Withdrawn
- 1994-05-20 IL IL10970394A patent/IL109703A0/en unknown
- 1994-11-18 PE PE1994255110A patent/PE31195A1/en not_active Application Discontinuation
-
1995
- 1995-11-17 OA OA60742A patent/OA10195A/en unknown
- 1995-11-20 NO NO954681A patent/NO954681D0/en unknown
- 1995-11-20 FI FI955587A patent/FI955587A/en not_active Application Discontinuation
- 1995-11-21 BG BG100154A patent/BG100154A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0699196A1 (en) | 1996-03-06 |
| CN1126473A (en) | 1996-07-10 |
| HUT73790A (en) | 1996-09-30 |
| PE31195A1 (en) | 1995-10-18 |
| CZ305195A3 (en) | 1996-06-12 |
| FI955587A0 (en) | 1995-11-20 |
| IL109703A0 (en) | 1994-08-26 |
| HU9503321D0 (en) | 1996-01-29 |
| NO954681L (en) | 1995-11-20 |
| BG100154A (en) | 1996-07-31 |
| WO1994027989A1 (en) | 1994-12-08 |
| CA2162921A1 (en) | 1994-12-08 |
| AU6928794A (en) | 1994-12-20 |
| TW279866B (en) | 1996-07-01 |
| GB9310635D0 (en) | 1993-07-07 |
| NO954681D0 (en) | 1995-11-20 |
| JPH08510455A (en) | 1996-11-05 |
| OA10195A (en) | 1996-12-18 |
| SK142495A3 (en) | 1996-06-05 |
| ZA943494B (en) | 1995-01-23 |
| FI955587A (en) | 1995-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9301000D0 (en) | Chemical compounds | |
| GB9312210D0 (en) | Chemical compounds | |
| GB9311682D0 (en) | Chemical compounds | |
| GB9305468D0 (en) | Chemical compounds | |
| PL311702A1 (en) | Chemical compounds | |
| GB9305469D0 (en) | Chemical compounds | |
| GB2280677B (en) | Chemical compounds | |
| GB9308421D0 (en) | Chemical compounds | |
| GB9305509D0 (en) | Chemical compounds | |
| GB9307749D0 (en) | Chemical compounds | |
| GB9305510D0 (en) | Chemical compounds | |
| GB9305459D0 (en) | Chemical compounds | |
| GB9305806D0 (en) | Chemical compounds | |
| GB9306941D0 (en) | Chemical compounds | |
| GB9302844D0 (en) | Chemical compounds | |
| GB9300882D0 (en) | Chemical compounds | |
| GB9304530D0 (en) | Chemical compounds | |
| GB9304640D0 (en) | Chemical compounds | |
| GB9304641D0 (en) | Chemical compounds | |
| GB9304642D0 (en) | Chemical compounds | |
| GB9303987D0 (en) | Chemical compounds | |
| GB9303902D0 (en) | Chemical compounds | |
| GB9303573D0 (en) | Chemical compounds | |
| GB9307809D0 (en) | Chemical compounds | |
| GB9303572D0 (en) | Chemical compounds |